Innovative Public Access Visualization Tools in Cardiovascular Disease: Supporting Providers, Patients, and Policy Makers With EARTH-HCM
Long-Term Efficacy and Safety Outcomes for Cardiac Myosin Inhibition in Adults With Symptomatic NYHA Class II–III Obstructive HCM
Home Course Outline Faculty Continuing Education Continuing Education Read more about Continuing Education
Remodeling Innovation: Applying Clinical Research and Real-World Experience with Cardiac Myosin Inhibition in HCM & Beyond